6317-56-2

Basic information

• Product Name: p-(phenylthio)benzyl alcohol
• Synonyms: p-(phenylthio)benzyl alcohol;4-(Phenylthio)Benzyl Chloride;(4-(chloromethyl)phenyl)(phenyl)sulfane;4-(Phenylthio)benzenemethanol;Einecs 228-658-6;NSC 43060;(4-Phenylsulfanylphenyl)Methanol;(4-(Phenylthio)
• CAS NO: 6317-56-2
• Molecular Formula: C₁₃H₁₂OS
• Molecular Weight: 216.29878
• EINECS: 228-658-6
• Product Categories: Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds
• Mol File: 6317-56-2.mol
• Article Data: 11

Chemical Properties

• Melting Point: 46-48°C
• Boiling Point: 390.2 °C at 760 mmHg
• Flash Point: 189.6 °C
• Appearance: Pale beige solid
• Density: 1.21 g/cm³
• Vapor Pressure: 8.66E-07mmHg at 25°C
• Refractive Index: 1.658
• Storage Temp.: -20?C Freezer
• PKA: 14.26±0.10(Predicted)
• CAS DataBase Reference: p-(phenylthio)benzyl alcohol(CAS DataBase Reference)
• NIST Chemistry Reference: p-(phenylthio)benzyl alcohol(6317-56-2)
• EPA Substance Registry System: p-(phenylthio)benzyl alcohol(6317-56-2)

Safety Data

• Hazardous Substances Data: 6317-56-2(Hazardous Substances Data)

Usage

Chemical Properties

Pale Beige Solid

Uses

An impurity of Fenticonazole nitrate (F279250), a new potent antimycotic compound.

InChI:InChI=1/C13H12OS/c14-10-11-6-8-13(9-7-11)15-12-4-2-1-3-5-12/h1-9,14H,10H2

Upstream product

• 1208-88-4 4-phenylsulfanyl-benzaldehyde 
• 6310-24-3 4-(phenylthio)benzoic acid 
• 139-66-2 diphenyl sulfide 
• 59016-93-2 p-hydroxymethylphenylboronic acid 
• 108-98-5 thiophenol 
• 1122-91-4 4-bromo-benzaldehyde 
• 18282-51-4 4-iodo-benzyl alcohol 
• 873-75-6 4-bromobenzenemethanol 
• 39248-81-2 methyl 4-phenylthiobenzoate 

Downstream Products

• 898535-26-7 methanesulfonic acid 4-phenylsulfanyl-benzyl ester 
• 6310-24-3 4-(phenylthio)benzoic acid 
• 66-39-7 4-(phenylsulfonyl)benzaldehyde 
• 1093117-21-5 (4-(bromomethyl)phenyl)(phenyl)sulfide 
• 72479-26-6 α-(2,4-dichlorophenyl)-β,N-imidazolylethyl 4-phenylthiobenzyl ether 
• 6317-59-5 1-cyanomethyl-4-phenylthiobenzene 
• 85554-28-5 (4-benzenesulfonyl-phenyl)-acetonitrile 
• 100-51-6 benzyl alcohol 
• 1208-87-3 1-phenylthio-4-chloromethyl-benzene 

Relevant articles and documents

Refining process, detection standard and application of fenticonazole nitrate

The invention belongs to the technical field of chemical synthesis and discloses a refining process of fenticonazole nitrate. The refining process comprises the following steps: 1) synthesizing an intermediate I, namely 4-benzene sulfydryl benzaldehyde; 2) synthesizing an intermediate II, namely 4-benzene sulfydryl phenylcarbinol; 3) synthesizing an intermediate III, namely 4-benzene sulfydryl benzyl chloride; 4) synthesizing a crude product of fenticonazole nitrate; and 5) refining fenticonazole nitrate. The invention further discloses a detection method of an intermediate of the fenticonazole nitrate and an application of the fenticonazole nitrate in medicines.

Method for synthesizing fenticonazole nitrate

The invention belongs to the technical field of chemical synthesis, and discloses a method for synthesizing fenticonazole nitrate. By the aid of a phase transfer catalytic method, condensation reaction is performed at the presence of sodium hydroxide. The method particularly includes the steps: 1) synthesizing 4-mercaptophenyl-benzaldehyde; 2) synthesizing 4-mercaptophenyl benzyl alcohol; 3) synthesizing 4-mercaptophenyl-benzyl chloride; 4) synthesizing fenticonazole nitrate crude products. Used reagents are low in cost and easy to obtain, synthesis cost is greatly reduced, operation is simpleand convenient, special requirements on equipment are omitted, and the method is more suitable for scale production.

Non-basic ligands for aminergic GPCRs: The discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders

Scaffold hopping from a non-basic series of 5-HT2A receptor antagonists developed in-house that possessed reduced activity in vivo enabled the discovery of a novel series of diaryl sulfones that gave excellent occupancy on oral dosing. Not only does this work further demonstrate that oral bioavailability of a given series can be enhanced by improving physicochemical parameters such as log P, but it corroborates the growing evidence that a protonated amine is not essential for affinity at aminergic GPCRs.